Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
Abstract Background Schistosomiasis is a devastating parasitic disease. The mainstay of schistosomiasis control is by praziquantel treatment. The study aimed to determine benefits of annual chemotherapy of schistosomiasis on development of protective immunity in school children in a selected endemic...
Main Authors: | Tawanda J. Chisango, Bongiwe Ndlovu, Arthur Vengesai, Agness Farai Nhidza, Edson P. Sibanda, Danai Zhou, Francisca Mutapi, Takafira Mduluza |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-3811-z |
Similar Items
-
Putting the treatment of paediatric schistosomiasis into context
by: Takafira Mduluza, et al.
Published: (2017-04-01) -
Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
by: Mark S. Pearson, et al.
Published: (2021-05-01) -
A new global strategy for the elimination of schistosomiasis
by: Allen G.P. Ross, M.D., Ph.D., et al.
Published: (2017-01-01) -
Schistosomiasis
by: Eka Husnawati, et al.
Published: (2016-06-01) -
Treatment of schistosomiasis: gathering stones together
by: J. R. Lambertucci
Published: (1995-04-01)